RESUMEN
BACKGROUND: Coxiella burnetii is a bacterium with extreme tenacity and contagiousness that is mainly transmitted by inhalation of contaminated aerosols. Nevertheless, a transmission by ticks is under discussion. We report a case of Q fever in an urban environment and far away from sheep breeding that caused a rare right-sided endocarditis. CASE PRESENTATION: A 55-year-old man who was in good health before the event developed a C. burnetii -endocarditis of the tricuspid valve. He had no contact with sheep and no recent travel in a rural or even endemic area. The infection originated in a strictly urban environment, and the patient's occupation as a cemetery gardener in Berlin, coupled with the close temporal and local exposure to wild boar, made a transmission by these animals a plausible hypothesis. The infection was confirmed by the German Reference Laboratory, and the patient recovered completely after treatment with doxycycline and hydrochlorquine. CONCLUSIONS: The specialities of this case report are the right-sided endocarditis and the transmission of C. burnetii in a metropolitan area without sheep contact. We think that this case should serve to increase awareness of the potential for Q fever infection even in non-rural areas.
Asunto(s)
Coxiella burnetii , Endocarditis Bacteriana , Fiebre Q , Válvula Tricúspide , Fiebre Q/transmisión , Fiebre Q/microbiología , Fiebre Q/diagnóstico , Fiebre Q/tratamiento farmacológico , Masculino , Persona de Mediana Edad , Humanos , Válvula Tricúspide/microbiología , Endocarditis Bacteriana/microbiología , Endocarditis Bacteriana/transmisión , Endocarditis Bacteriana/tratamiento farmacológico , Coxiella burnetii/aislamiento & purificación , Animales , Antibacterianos/uso terapéutico , Doxiciclina/uso terapéutico , OvinosRESUMEN
Q fever is a worldwide zoonosis due to Coxiella burnetii, responsible for endocarditis and endovascular infections. Since the 1990s, the combination hydroxychloroquineâ+âdoxycycline has constituted the curative and prophylactic treatment in persistent focalized Q fever. This combination appears to have significantly reduced the treatment's duration (from 60 to 26â months), yet substantial evidence of effectiveness remains lacking. Data are mostly based on in vitro and observational studies. We conducted a literature review to assess the effectiveness of this therapy, along with potential alternatives. The proposed in vitro mechanism of action describes the inhibition of Coxiella replication by doxycycline through the restoration of its bactericidal activity (inhibited in acidic environment) by alkalinization of phagolysosome-like vacuoles with hydroxychloroquine. So far, the rarity and heterogeneous presentation of cases have made it challenging to design prospective studies with statistical power. The main studies supporting this treatment are retrospective cohorts, dating back to the 1990s-2000s. Retrospective studies from the large Dutch outbreak of Q fever (>4000 cases between 2007 and 2010) did not corroborate a clear benefit of this combination, notably in comparison with other regimens. Thus, there is still no consensus among the medical community on this issue. However insufficient the evidence, today the doxycyclineâ+âhydroxychloroquine combination remains the regimen with the largest clinical experience in the treatment of 'chronic' Q fever. Reinforcing the guidelines' level of evidence is critical. We herein propose the creation of an extensive international registry, followed by a prospective cohort or ideally a randomized controlled trial.
Asunto(s)
Antibacterianos , Coxiella burnetii , Doxiciclina , Hidroxicloroquina , Fiebre Q , Ensayos Clínicos Controlados Aleatorios como Asunto , Fiebre Q/tratamiento farmacológico , Humanos , Hidroxicloroquina/uso terapéutico , Doxiciclina/uso terapéutico , Antibacterianos/uso terapéutico , Coxiella burnetii/efectos de los fármacos , Quimioterapia Combinada , Resultado del TratamientoRESUMEN
Since 1999, doxycycline and hydroxychloroquine have been the recommended treatment for chronic Q fever, a life-threatening disease caused by the bacterial pathogen, Coxiella burnetii. Despite the duration of its use, the treatment is not ideal due to the lengthy treatment time, high mortality rate, resistant strains, and the potential for contraindicated usage. A literature search was conducted to identify studies that screened large panels of drugs against C. burnetii to identify novel targets with potential efficacy against C. burnetii. Twelve candidate antimicrobials approved for use in humans by the US Food and Drug Administration were selected and minimum inhibitory concentrations (MICs) were determined against the low virulence strain Nine Mile phase II. Rifabutin and rifaximin were the best performing antibiotics tested with MICs of ≤0.01 µg mL-1. Further screening of these top candidates was conducted alongside two drugs from the same class, rifampin, well-characterized, and rifapentine, not previously reported against C. burnetii. These were screened against virulent strains of C. burnetii representing three clinically relevant genotypes. Rifapentine was the most effective in the human monocytic leukemia cell line, THP-1, with a MIC ≤0.01 µg mL-1. In the human kidney epithelial cell line, A-498, efficacy of rifapentine, rifampin, and rifabutin varied across C. burnetii strains with MICs between ≤0.001 and 0.01 µg mL-1. Rifampin, rifabutin, and rifapentine were all bactericidal against C. burnetii; however, rifabutin and rifapentine demonstrated impressive bactericidal activity as low as 0.1 µg mL-1 and should be further explored as alternative Q fever treatments given their efficacy in vitro. IMPORTANCE: This work will help inform investigators and physicians about potential alternative antimicrobial therapies targeting the causative agent of Q fever, Coxiella burnetii. Chronic Q fever is difficult to treat, and alternative antimicrobials are needed. This manuscript explores the efficacy of rifamycin antibiotics against virulent strains of C. burnetii representing three clinically relevant genotypes in vitro. Importantly, this study determines the susceptibility of C. burnetii to rifapentine, which has not been previously reported. Evaluation of the bactericidal activity of the rifamycins reveals that rifabutin and rifapentine are bactericidal at low concentrations, which is unusual for antibiotics against C. burnetii.
Asunto(s)
Antibacterianos , Coxiella burnetii , Pruebas de Sensibilidad Microbiana , Fiebre Q , Rifampin , Rifamicinas , Humanos , Rifampin/farmacología , Rifampin/análogos & derivados , Antibacterianos/farmacología , Coxiella burnetii/efectos de los fármacos , Coxiella burnetii/genética , Rifamicinas/farmacología , Fiebre Q/tratamiento farmacológico , Fiebre Q/microbiología , Rifabutina/farmacología , Rifabutina/análogos & derivados , Línea CelularRESUMEN
INTRODUCTION: Q fever, a zoonotic disease caused by Coxiella burnetii (C. burnetii), presents diagnostic challenges due to its clinical and radiological nonspecificity, which often mimics community-acquired pneumonia, coupled with the limitations of traditional diagnostic methods. Metagenomic next-generation sequencing (mNGS) has become an indispensable tool in clinical diagnostics for its high-throughput pathogen identification capabilities. Herein, we detail a case of acute Q fever pneumonia diagnosed with mNGS. CASE PRESENTATION: The patient exhibited symptoms of fever, cough, expectoration, and diarrhea for three days, with the pathogen undetected in initial laboratory assessments. Bronchoscopy and bronchoalveolar lavage (BAL) were conducted, leading to the identification of C. burnetii in the lavage fluid via mNGS. Consequently, the patient was promptly initiated on a treatment regimen of 100 mg doxycycline, administered orally every 12 hours. RESULTS: Post-treatment, the patient's temperature normalized, and a full recovery was observed. The follow-up chest CT scan revealed complete resolution of the right lower lobe consolidation. CONCLUSIONS: The clinical presentation of Q fever pneumonia lacks specificity, making diagnosis based solely on symptoms and imaging challenging. mNGS offers a superior alternative for identifying elusive or rarely cultured pathogens.
Asunto(s)
Coxiella burnetii , Secuenciación de Nucleótidos de Alto Rendimiento , Metagenómica , Fiebre Q , Humanos , Fiebre Q/diagnóstico , Fiebre Q/tratamiento farmacológico , Fiebre Q/microbiología , Coxiella burnetii/genética , Coxiella burnetii/aislamiento & purificación , Metagenómica/métodos , Masculino , Neumonía Bacteriana/diagnóstico , Neumonía Bacteriana/microbiología , Neumonía Bacteriana/tratamiento farmacológico , Antibacterianos/uso terapéutico , Doxiciclina/uso terapéutico , Líquido del Lavado Bronquioalveolar/microbiología , Persona de Mediana Edad , Tomografía Computarizada por Rayos XRESUMEN
The patient, a 43-year-old male, was admitted to the hospital with gradually aggravated exertional palpitations and chest tightness over a 2-day period. Upon hospital admission, a cardiac ultrasound revealed aortic valve redundancy, however multiple blood culture investigations came back negative. Blood mNGS was perfected, revealing Coxiella burnetii, and the diagnosis of Q fever (query fever) was established. The temperature and inflammatory indices of the patient were all normal with the treatment of vancomycin before cardiac surgery. But for the potential liver damage of and the Coxiella burnetii was still positive in the anti-phase II IgG titer, the doxycycline and hydroxychloroquine instead of vancomycin were applied for the patient. Despite receiving standardized anti-infective therapy of doxycycline combined with hydroxychloroquine, this patient had fever and increased leukocytes following surgery. After the addition of vancomycin as an anti-infective treatment, the temperature and leukocytes improved quickly. During the treatment of vancomycin, a discovery of liver injury may have resulted. These findings provide new therapy options for future professionals.
Asunto(s)
Coxiella burnetii , Endocarditis Bacteriana , Fiebre Q , Masculino , Humanos , Adulto , Fiebre Q/diagnóstico , Fiebre Q/tratamiento farmacológico , Vancomicina/uso terapéutico , Doxiciclina/uso terapéutico , Hidroxicloroquina , Endocarditis Bacteriana/diagnóstico , Endocarditis Bacteriana/tratamiento farmacológicoRESUMEN
Coxiella burnetii is the causative agent in Q fever, a zoonotic disease. Ocular manifestations of this disease are extremely rare and have been infrequently reported. In this report, we describe a rare case of chorioretinitis in a patient incompletely treated for Q fever. We highlight the unique ocular manifestation with multimodal imaging, and the importance of a thorough history and prompt and correct treatment of the disease with systemic therapy. [Ophthalmic Surg Lasers Imaging Retina 2024;55:412-414.].
Asunto(s)
Coriorretinitis , Coxiella burnetii , Infecciones Bacterianas del Ojo , Angiografía con Fluoresceína , Fiebre Q , Tomografía de Coherencia Óptica , Humanos , Coriorretinitis/diagnóstico , Coriorretinitis/microbiología , Fiebre Q/diagnóstico , Fiebre Q/complicaciones , Fiebre Q/microbiología , Fiebre Q/tratamiento farmacológico , Infecciones Bacterianas del Ojo/diagnóstico , Infecciones Bacterianas del Ojo/microbiología , Infecciones Bacterianas del Ojo/tratamiento farmacológico , Tomografía de Coherencia Óptica/métodos , Coxiella burnetii/aislamiento & purificación , Angiografía con Fluoresceína/métodos , Masculino , Antibacterianos/uso terapéutico , Fondo de Ojo , Imagen Multimodal , Persona de Mediana EdadRESUMEN
Background: Q fever has significant consequences for patients with persistent localized infection. A combination of doxycycline with hydroxychloroquine, for at least 18-24 months, is the first-line therapy. The use of serology as a prognostic marker during therapy is controversial. Methods: A retrospective, observational cohort study in two outpatient clinics in northern Israel. All adults with persistent Q fever (2015-2021) were included in the study. Clinical failure was defined as relapse or death related to Q fever after end of treatment (EOT). Serological cure was defined as phase 1 IgG ≤800 or a four-fold decrease at EOT. Results: Twenty-two patients were included in the study, with a median follow up of 40 months (IQR = 28.5-63.5), and median treatment duration of 28.5 months (IQR = 21.8-50.5). Clinical cure occurred in 18 patients (82%), serological cure in 10 (45%). Phase 1 IgG at presentation was significantly higher in the clinical failure group (median 9600 vs. 3200 in the clinical cure group, p = 0.019), and at 6-12 months after EOT (median 6400 vs. 800 respectively, p = 0.03). Phase 1 IgG levels at 1 year and EOT were similar in both groups. Positive phase 2 IgM after one year of therapy correlated with clinical failure (p = 0.038), but not at EOT or after EOT. Conclusion: Phase 1 IgG levels at presentation, phase 2 IgM at 1 year, and Phase 1 IgG 6-12 months after EOT were associated with clinical failure in patients with persistent Q fever.
Asunto(s)
Antibacterianos , Doxiciclina , Fiebre Q , Fiebre Q/diagnóstico , Fiebre Q/tratamiento farmacológico , Humanos , Estudios Retrospectivos , Masculino , Femenino , Persona de Mediana Edad , Doxiciclina/uso terapéutico , Antibacterianos/uso terapéutico , Adulto , Pronóstico , Inmunoglobulina G/sangre , Israel/epidemiología , Hidroxicloroquina/uso terapéutico , Estudios de Cohortes , Anticuerpos Antibacterianos/sangre , Coxiella burnetii/inmunología , Anciano , Pruebas SerológicasAsunto(s)
Neumonía , Fiebre Q , Humanos , Animales , Fiebre Q/complicaciones , Fiebre Q/diagnóstico , Fiebre Q/tratamiento farmacológico , Enfermedades Raras , ZoonosisRESUMEN
Osteomyelitis in children due to Q fever is a rare occurrence. In this study, we review 25 pediatric cases of this disease entity. The mean age of these 25 patients was 3.7years (range, 2-7 years). The risk factor for infection was history of contact with animals, such as cattle and sheep (23/25, 92.0%). The most common sites of infection were foot and ankle (12/25, 48.0%). The diagnosis of Q fever was confirmed by serologic testing in 25 children. On PCR, Coxiella burnetii was detected in 17 cases and it was not detected in the remaining five cases. A total of 22 children were treated with antibiotics, of which 15 received surgical treatment. The composition and duration of treatment varied greatly. Only 18 patients achieved significant recovery of joint mobility after drug and/or surgical treatment. Our current literature review show that the clinical manifestations of Q fever osteomyelitis in children are atypical. In the absence of serological test results, mNGS identification may be a good option. Compared with the guidelines that recommend doxycycline combined with hydroxychloroquine, we recommend that ciprofloxacin-based treatment combined with rifampicin or sulfamethoxazole/trimethoprim should be preferred in children under the age of 8 years, and the need for performing combined surgical debridement and determining the treatment duration should be evaluated according to their actual clinical situation.
Asunto(s)
Coxiella burnetii , Osteomielitis , Fiebre Q , Humanos , Niño , Animales , Bovinos , Ovinos , Preescolar , Fiebre Q/diagnóstico , Fiebre Q/tratamiento farmacológico , Fiebre Q/epidemiología , Estudios Retrospectivos , Coxiella burnetii/genética , Antibacterianos/uso terapéutico , Osteomielitis/diagnóstico , Osteomielitis/tratamiento farmacológicoAsunto(s)
Huesos Metatarsianos , Osteomielitis , Fiebre Q , Humanos , Niño , Fiebre Q/complicaciones , Fiebre Q/diagnóstico , Fiebre Q/tratamiento farmacológico , Huesos Metatarsianos/diagnóstico por imagen , Osteomielitis/diagnóstico , Osteomielitis/tratamiento farmacológico , Antibacterianos/uso terapéuticoRESUMEN
Q fever is an important zoonotic disease caused by the pathogen Coxiella burnetii, which is inhaled into the body through the respiratory tract leading to acute symptoms. Severe acute Q fever may result in complications, such as pneumonia, hepatitis, or myocarditis, and some patients may develop chronic Q fever after incomplete treatment. Local persistent C. burnetii infection may lead to chronic Q fever that often requires surgery and anti-infection treatment for several years, seriously endangering patient health and increasing the economic burden for families. The clinicians' lack of awareness of the disease may be one reason leading to a delay in treatment. Here, a case of Q fever in a 53-year-old male patient, which was diagnosed by next generation sequencing and exhibited a distinct computed tomographic feature, is reported, with the aim of improving clinical knowledge of this disease. Following diagnosis, the patient was treated with 0.1 g doxycycline, orally, twice daily, and 0.5 g chloramphenicol, orally, three times daily, leading to improvement of symptoms and discharge from hospital.
Asunto(s)
Nódulos Pulmonares Múltiples , Fiebre Q , Masculino , Animales , Humanos , Persona de Mediana Edad , Fiebre Q/complicaciones , Fiebre Q/diagnóstico , Fiebre Q/tratamiento farmacológico , Zoonosis , Cloranfenicol , Doxiciclina/uso terapéuticoRESUMEN
BACKGROUND: Organizing pneumonia is a non-specific inflammatory response to various types of damage to the lungs. It is usually considered bacterial pneumonia that has not been absorbed for more than 4 weeks, accompanied by granulomas and fibrosis. Lung lesions in patients with organizing pneumonia are usually irreversible and the prognosis is relatively poor. Coxiella burnetii can cause Q fever. Acute Q fever usually presents as a self-limiting febrile illness with a good prognosis, but there are few cases of coexisting organizing pneumonia. We report a case of organizing pneumonia secondary to Coxiella burnetii infection. METHODS: Percutaneous lung biopsy, Next-generation sequencing (NGS). RESULTS: Percutaneous lung biopsy showed the existence of organizing pneumonia, and external examination of NGS showed the existence of Coxiella burnetii infection. After symptomatic treatment with azithromycin and glucocorticoids, the patient improved and was discharged from the hospital. CONCLUSIONS: For lesions with obvious heterogeneous enhancement on chest CT imaging, percutaneous lung biopsy or bronchoscopy should be performed promptly to obtain pathological tissue, and NGS should be used for definite diagnosis if necessary.
Asunto(s)
Coxiella burnetii , Neumonía Organizada , Neumonía , Fiebre Q , Humanos , Fiebre Q/complicaciones , Fiebre Q/diagnóstico , Fiebre Q/tratamiento farmacológico , Neumonía/diagnóstico , Pulmón/diagnóstico por imagen , Pulmón/patologíaRESUMEN
BACKGROUND: Spinal infection caused by Coxiella burnetii is rare and difficult to diagnose. Here we reported a case of spinal infection from Coxiella burnetii detected by the metagenomic next-generation sequencing (mNGS). CASE PRESENTATION: A 66-year-old male farmer with no medical history reported severe sharp low back pain, numbness and lower limb weakness for three years. Magnetic resonance imaging (MRI) revealed bone destruction and spinal cord compression within L1 and L2. mNGS testing showed that the inspected specimen collected from spinal lesion was detected positively for Coxiella burnetii. After receiving the combined treatment of antibiotic therapy and surgical intervention, the patient recovered well, and the sagittal MRI showed that vertebral edema signals disappeared and the graft of bone fused 16 months after surgery. CONCLUSION: The mNGS may be benefit for early diagnosis and intervention of non-specific spinal infection, and future studies should validate its effectiveness for clinical use in spinal infections. Additionally, antibiotic therapy combined with surgical intervention plays an important role on the treatment of spinal infection caused by Coxiella burnetii.
Asunto(s)
Coxiella burnetii , Fiebre Q , Masculino , Humanos , Anciano , Coxiella burnetii/genética , Fiebre Q/diagnóstico , Fiebre Q/tratamiento farmacológico , Antibacterianos/uso terapéutico , Terapia Combinada , Imagen por Resonancia MagnéticaRESUMEN
The objective of this study was to evaluate the effectiveness of the recommended treatment for endovascular infections due to Coxiella burnetii. This single-center retrospective study was conducted in 13 patients with endovascular infection due to C. burnetii between January 2001 and December 2020 for a definite or possible endovascular infection due to C. burnetii with a minimum follow-up of 18 months post-infection. Clinical and biological data, including serology, blood and tissue PCR results, doxycycline and hydroxychloroquine assays were collected. Among the 13 patients, 11 had endocarditis (8 definite and 3 possible) and 2 had a vascular infection. At the time of diagnosis, fever was present in only 46% of cases. In case of endocarditis, 73% of patients had a pathological echocardiography. Biologically, the CRP level was low (52 mg/l ± 44). Autoimmune antibodies (antinuclear factor, neutrophil anticytoplasm) were present in 23% of patients. At the time of diagnosis, tissue PCR was very sensitive (100%) unlike blood or serum (29%). Blood levels of doxycycline and hydroxychloroquine were within expected values. Only one patient experienced treatment failure at two years, requiring surgery. For the 7 patients whose phase I IgG titres fell below 1/800, a minimum of 18 months of treatment was necessary. In the long term, the clinical and biological cure was 100% and 92% respectively, underlining the importance of monitoring the serum dosages of doxycycline and hydroxychloroquine. Given its sensitivity, tissue PCR could be added to the major Duke criteria.
Asunto(s)
Endocarditis Bacteriana , Endocarditis , Fiebre Q , Humanos , Doxiciclina/uso terapéutico , Antibacterianos/uso terapéutico , Fiebre Q/diagnóstico , Fiebre Q/tratamiento farmacológico , Hidroxicloroquina/uso terapéutico , Estudios de Seguimiento , Estudios Retrospectivos , Endocarditis Bacteriana/tratamiento farmacológico , Endocarditis/tratamiento farmacológicoRESUMEN
BACKGROUND: Coxiella burnetii (C. burnetii) is the causative agent of Q fever and is found worldwide; however, prosthetic joint infections caused by C. burnetii are rarely seen. Because of advances in molecular diagnostic techniques, prosthetic joint infection (PJI) caused by C. burnetii can now be diagnosed. CASE PRESENTATION: A 77-year-old male who had undergone total knee arthroplasty had a displaced prosthesis and periprosthetic osteolysis; he had no obvious signs of infection, and microbiological culture was negative. However, C. burnetii was detected by metagenomic next-generation sequencing (mNGS) and pathogen-targeted next-generation sequencing (ptNGS). Finally, polymerase chain reaction (PCR) confirmed the diagnosis of C. burnetii prosthetic joint infection (PJI). After revision surgery (one-stage revision) and oral antibiotics (doxycycline and moxifloxacin hydrochloride), the patient's symptoms disappeared, and he regained the ability to walk. During the 6-month follow-up, the patient's knee showed no signs of swelling, pain or the recurrence of infection, and he experienced no significant complications. We also present a review of the literature for other cases of C. burnetii PJI. CONCLUSIONS: The symptoms of C. burnetii PJI may be different from those of Q fever, which may lead to misdiagnosis. mNGS and ptNGS may be helpful for the identification of C. burnetii. Once the diagnosis of C. burnetii PJI is confirmed, doxycycline in combination with a fluoroquinolone can be effectively administered after revision surgery.
Asunto(s)
Artritis Infecciosa , Coxiella burnetii , Prótesis Articulares , Fiebre Q , Masculino , Humanos , Anciano , Coxiella burnetii/genética , Fiebre Q/diagnóstico , Fiebre Q/tratamiento farmacológico , Fiebre Q/microbiología , Doxiciclina , Secuenciación de Nucleótidos de Alto Rendimiento/métodosRESUMEN
Q fever osteomyelitis has been rarely reported in children. This infection has an unclear pathophysiology and the optimal therapy is unknown. We report a 2-year-old girl with Coxiella burnetti recurrent multifocal osteomyelitis: femur, metatarsal, cuneiform, and calcaneus. We highlight the complicated diagnosis and management of this case and the importance of considering Q fever in children with chronic-recurrent multifocal osteomyelitis.
Asunto(s)
Coxiella burnetii , Osteomielitis , Fiebre Q , Antibacterianos/uso terapéutico , Niño , Preescolar , Femenino , Humanos , Osteomielitis/diagnóstico , Osteomielitis/tratamiento farmacológico , Osteomielitis/etiología , Fiebre Q/complicaciones , Fiebre Q/diagnóstico , Fiebre Q/tratamiento farmacológicoRESUMEN
Coxiella burnetti is the causative organism of the zoonotic infection Q fever, of which endocarditis is one of the most common manifestations of the chronic form. Polymicrobial endocarditis with Q fever is extremely rare and is yet to be described among an Australasian cohort. SUMMARY: We present the case of a 32-year-old gardener with culture-negative chronic Q fever prosthetic valve endocarditis concomitant with another bacterial pathogen, leading to aortic root abscess formation, requiring a Bentall procedure, extracorporeal membrane oxygenation, and prolonged antimicrobial therapy, with a fatal outcome. Unique to our case, Q fever was identified early, and the second pathogen was only detected on 16S ribosomal RNA (rRNA) polymerase chain reaction of explanted valvular tissue. Given the high risk for morbidity, we recommend that screening for Q fever in endemic areas among patients with infective endocarditis from other etiologies be considered. In addition, this case highlights the role for Q fever vaccination of the at-risk population with underlying valvulopathy. Furthermore, clinicians should be aware of polymicrobial infective endocarditis and suspicious in case of patients with atypical clinical features.
Asunto(s)
Coxiella burnetii , Endocarditis Bacteriana , Endocarditis , Prótesis Valvulares Cardíacas , Fiebre Q , Adulto , Coxiella burnetii/genética , Endocarditis/diagnóstico , Endocarditis/tratamiento farmacológico , Endocarditis Bacteriana/diagnóstico , Endocarditis Bacteriana/tratamiento farmacológico , Endocarditis Bacteriana/microbiología , Prótesis Valvulares Cardíacas/efectos adversos , Prótesis Valvulares Cardíacas/microbiología , Humanos , Reacción en Cadena de la Polimerasa , Fiebre Q/complicaciones , Fiebre Q/diagnóstico , Fiebre Q/tratamiento farmacológico , ARN Ribosómico 16S/genéticaRESUMEN
Q fever is a worldwide spread zoonotic disease, caused by the gram-negative intracellular bacillus Coxiella burnetii. Apart from its most common manifestations, Q fever has been reported to occasionally mimic autoimmune diseases. We herein present a case of acute Q fever in a 69-year-old man, manifesting as prolonged fever with pneumonitis, in whom biopsy of the temporal artery revealed giant cell arteritis. Moreover, PCR testing of the biopsy specimen was positive for Coxiella burnetii, thus further supporting the possibly infectious etiology of some cases of biopsy proven giant cell arteritis, with implications for treatment.